Bausch Health Companies | Passivo Circulante



Current Liabilities Alterar Data
Amgen USD 23.1B 2.79B 2024-12
ANI Pharmaceuticals USD 193.68M 3.75M 2024-12
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bausch Health Companies USD 6.75B 2.25B 2024-12
Biogen USD 5.53B 103.8M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 140.77M 14.56M 2024-12
Danaher USD 6.64B 153M 2025-03
Drreddys Laboratories INR 131.95B 2.65B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Gilead Sciences USD 12B 279M 2024-12
Novo Nordisk 208.36B 20.45B 2024-09
Pacira USD 309.92M 3.52M 2024-12
Perrigo USD 1.04B 406.3M 2024-12
Prestige Brands USD 102.54M 4.36M 2024-12
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Zoetis USD 3.41B 1.71B 2024-12



Bausch Health Companies Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.